---
figid: PMC4041145__1756-9966-33-37-1
figtitle: Akt and NFKB signaling in drug resistance mechanism of tumor cells
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Citrus macrophylla
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC4041145
filename: 1756-9966-33-37-1.jpg
figlink: /pmc/articles/PMC4041145/figure/F1/
number: F1
caption: The role of Akt and NF-κB signaling in drug resistance mechanism of tumor
  cells. Several drugs induce the activation of Akt and NF-κB signaling pathways.
  Akt activation inhibits the P53 and BAD pathways leading to cell survival. Akt also
  stimulates Ikk, which inhibits IκB and triggers NF-κB signaling pathway. NF-κB activates
  C-Myc and COX 2 that are mainly involved in cell proliferation and angiogenesis,
  respectively. Both Akt and NF-κB activate the antiapoptotic proteins Bcl-2 and Bcl-xL,
  inhibiting the Cytochrome-c release from mitochondria, and Cyclin D1, which contributes
  to cell cycle progression. Akt and NF-κB also inhibit the caspase cascade by XIAP
  and Survivin activation, respectively.
papertitle: 'The multiple facets of drug resistance: one history, different approaches.'
reftext: Evandro Luís Niero, et al. J Exp Clin Cancer Res. 2014;33(1):37-37.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9780709
figid_alias: PMC4041145__F1
figtype: Figure
redirect_from: /figures/PMC4041145__F1
ndex: 7a6f1710-debc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4041145__1756-9966-33-37-1.html
  '@type': Dataset
  description: The role of Akt and NF-κB signaling in drug resistance mechanism of
    tumor cells. Several drugs induce the activation of Akt and NF-κB signaling pathways.
    Akt activation inhibits the P53 and BAD pathways leading to cell survival. Akt
    also stimulates Ikk, which inhibits IκB and triggers NF-κB signaling pathway.
    NF-κB activates C-Myc and COX 2 that are mainly involved in cell proliferation
    and angiogenesis, respectively. Both Akt and NF-κB activate the antiapoptotic
    proteins Bcl-2 and Bcl-xL, inhibiting the Cytochrome-c release from mitochondria,
    and Cyclin D1, which contributes to cell cycle progression. Akt and NF-κB also
    inhibit the caspase cascade by XIAP and Survivin activation, respectively.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nfkbib
  - Nfkb1
  - Akt1
  - Xiap
  - Mdm2
  - COX2
  - Ptgs2
  - Cox4i1
  - Trp53
  - Myc
  - Nol3
  - Bcl2
  - Bad
  - Bcl2l1
  - NFKB1
  - AKT1
  - AKT2
  - AKT3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - XIAP
  - MDM2
  - PTGS2
  - MTCO2P12
  - COX8A
  - CPOX
  - COX5A
  - COX5B
  - COX6C
  - COX7C
  - .na.character
  - COX4I1
  - COX4I2
  - COX6A1
  - COX6A2
  - COX6B1
  - COX6B2
  - COX7A1
  - COX7A2
  - COX7B
  - COX7B2
  - COX8C
  - TP53
  - TP63
  - TP73
  - MYC
  - BCL2
  - BAD
  - Tp53
  - Ccne1
  - Dif
  - dl
  - Rel
  - Akt
  - IKKepsilon
  - key
  - IKKbeta
  - COX4
  - p53
  - betaTub60D
  - hth
  - CycE
  - cyc
  - Debcl
  - cass
  - xiap
  - birc5a
  - mdm2
  - tp53
  - myca
  - chmp2a
  - badb
  - Cancer
---
